GBE1 — Glycogen Branching Enzyme 1

GBE1 — Glycogen Branching Enzyme 1

Introduction

Gbe1 — Glycogen Branching Enzyme 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bruno2006]
<table> [@roby2004]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.2em;">GBE1</th></tr> [@ziemssen2008]
<tr><td colspan="2" style="text-align:center;font-style:italic;">Glycogen Branching Enzyme 1</td></tr> [@mccready2007]
<tr><th style="width:40%;">Gene Symbol</th><td>GBE1</td></tr>
<tr><th>Full Name</th><td>Glycogen Branching Enzyme 1</td></tr>
<tr><th>Chromosome</th><td>3p14</td></tr>
<tr><th>NCBI Gene ID</th><td>[2635](https://www.ncbi.nlm.nih.gov/gene/2635)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000104408](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000104408)</td></tr>
<tr><th>OMIM</th><td>[607589](https://www.omim.org/entry/607589)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y2R9](https://www.uniprot.org/uniprot/Q9Y2R9)</td></tr>
<tr><th>Associated Diseases</th><td>Adult Polyglucosan Body Disease, Glycogen Storage Disease Type IV</td></tr>
<tr><th>Expression</th><td>Liver, Muscle, Brain, Heart</td></tr>
</table>
</div>

Overview

GBE1 — Glycogen Branching Enzyme 1

Introduction

Gbe1 — Glycogen Branching Enzyme 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@bruno2006]
<table> [@roby2004]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.2em;">GBE1</th></tr> [@ziemssen2008]
<tr><td colspan="2" style="text-align:center;font-style:italic;">Glycogen Branching Enzyme 1</td></tr> [@mccready2007]
<tr><th style="width:40%;">Gene Symbol</th><td>GBE1</td></tr>
<tr><th>Full Name</th><td>Glycogen Branching Enzyme 1</td></tr>
<tr><th>Chromosome</th><td>3p14</td></tr>
<tr><th>NCBI Gene ID</th><td>[2635](https://www.ncbi.nlm.nih.gov/gene/2635)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000104408](https://www.ensembl.org/Homo_species/Gene/Summary?g=ENSG00000104408)</td></tr>
<tr><th>OMIM</th><td>[607589](https://www.omim.org/entry/607589)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y2R9](https://www.uniprot.org/uniprot/Q9Y2R9)</td></tr>
<tr><th>Associated Diseases</th><td>Adult Polyglucosan Body Disease, Glycogen Storage Disease Type IV</td></tr>
<tr><th>Expression</th><td>Liver, Muscle, Brain, Heart</td></tr>
</table>
</div>

Overview

GBE1 (Glycogen Branching Enzyme 1) is a gene located on chromosome 3p14 that encodes the glycogen branching enzyme, also known as amylo-(1,4 to 1,6)-transglycosylase. This enzyme catalyzes the formation of branch points in glycogen by transferring terminal glucose residues from one chain to a hydroxyl group at the C-6 position of an interior glucose residue. The branching of glycogen is essential for its solubility and for creating numerous non-reducing ends that can be rapidly mobilized during energy demand.

Function

The glycogen branching enzyme (GBE) plays a critical role in glycogen metabolism:

• Catalyzes the formation of alpha-1,6-glycosidic bonds, creating branch points
• Increases the solubility of glycogen by preventing long linear chains
• Creates numerous non-reducing ends for rapid glycogenolysis
• Essential for proper glycogen storage and mobilization
• The enzyme transfers segments of 6-8 glucose residues to create branches

Disease Associations

Adult Polyglucosan Body Disease (APBD)

APBD is a late-onset glycogen storage disorder caused by GBE1 mutations. It is characterized by:

• Accumulation of polyglucosan bodies (abnormal glycogen deposits) in [neurons](/entities/neurons) and muscle
• Progressive neurogenic bladder
• Peripheral neuropathy
• Cognitive decline in some cases
• Variable age of onset (typically 40-60 years)

Neurodegeneration

The accumulation of polyglucosan bodies in neurons is thought to contribute to neurodegeneration through:

• Impaired cellular energy metabolism
• Disruption of [autophagy](/entities/autophagy) and lysosomal function
• Endoplasmic reticulum stress
• Progressive loss of neuronal function

Therapeutic Implications

• No disease-modifying treatment currently available
• Dietary interventions to reduce glycogen accumulation are being explored
• Gene therapy approaches are under investigation
• Supportive care for neurological symptoms

Key Publications

See Also

• [Adult Polyglucosan Body Disease](/diseases/adult-polyglucosan-body-disease)
• [Glycogen Storage Disorders](/entities/glycogen-storage-disorders)
• [Neurodegeneration](/diseases/neurodegeneration)

External Links

• [NCBI Gene: GBE1](https://www.ncbi.nlm.nih.gov/gene/2635)
• [UniProt: GBE1](https://www.uniprot.org/uniprot/Q9Y2R9)

Pathophysiology

Polyglucosan Body Formation

The accumulation of polyglucosan bodies (also known as Lafora bodies) is a hallmark of Adult Polyglucosan Body Disease (APBD). These abnormal glycogen deposits consist of poorly branched glycogen-like material that is resistant to degradation. The formation of polyglucosan bodies is thought to occur due to:

• Impaired glycogen branching due to GBE1 dysfunction
• Abnormal glycogen structure that resists normal catabolism
• Accumulation of these abnormal deposits in lysosomes and cytoplasm
• Progressive interference with cellular function

Tissue-Specific Effects

GBE1 deficiency affects multiple tissues:

• Peripheral nerve: Accumulation in axons leads to neuropathy
• Muscle: Myopathic changes and weakness
• Brain: Cognitive decline and neuronal dysfunction
• Liver: Variable involvement depending on mutation

Diagnosis

Genetic Testing

• Sequence analysis of GBE1 gene
• Identification of pathogenic variants
• Carrier testing for family members

Biomarkers

• Elevated glycogen in muscle biopsy
• Polyglucosan bodies in nerve/muscle biopsy
• Reduced GBE1 enzyme activity

Treatment

Current Management

• Supportive care for neurological symptoms
• Physical therapy for weakness
• Occupational therapy for daily activities
• Regular monitoring of disease progression

Emerging Therapies

• Gene therapy approaches
• Enzyme replacement strategies
• Small molecule therapies to reduce polyglucosan accumulation

Background

The study of Gbe1 — Glycogen Branching Enzyme 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References